Abiopharma

AGENCIA COMERCIAL SPIRITS LTD. (AGCC) Files Form 6-K

CBL INTERNATIONAL LTD (BANL) Files Form 6-K

LiveOne (Nasdaq: LVO) Eliminates $15M+ Short-Term Liabilities, Delivering $13M+ in Cash Savings; Expands Stock Conversion Program to $15M+ at $7.50 per Share, with $8M Completed

MIMEDX to Host First Quarter 2026 Operating and Financial Results Conference Call on April 29

PROSPERITY BANCSHARES AND STELLAR BANCORP ANNOUNCE RECEIPT OF REGULATORY APPROVALS FOR PROSPERITYS PENDING ACQUISITION OF STELLAR

Humacyte Appoints Jim Mercadante as Chief Commercial Officer

OPKO Health’s ModeX Therapeutics Begins Clinical Trial of Tetraspecific Antibody for Treatment of B-cell Lymphomas

IP Strategy Highlights the Story Global Wallet: Advancing Access to Programmable IP Infrastructure

PMV Pharmaceuticals Announces Board Chair Transition

The Beauty Health Company Announces Corporate Rebrand to SkinHealth Systems, Reflecting Evolution into a Clinically Driven, Science-Backed Medical Aesthetics Platform

Las Vegas Metropolitan Police Signs Five-Year WrapReality™ Contract Renewal with WRAP® to Advance Immersive Training and Non-Lethal Response™ Preparedness

Innoviz Technologies Launches InnovizTwo Ultra Long-Range (ULR) LiDAR, Delivering up to 1-Kilometer Sensing to Power Next-Generation Physical AI for Automotive and SMART Applications

Tuya Filed 2025 Annual Report on Form 20-F and Released Environmental, Social and Governance Report

Madrigal Pharmaceuticals to Release First-Quarter 2026 Financial Results and Host Webcast on May 6, 2026

Arteris to Announce Financial Results for the First Quarter 2026 on Tuesday, May 12, 2026